ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,886Medicare Part D Prescriptions Filled, Including Refills

Rank: 91 out of 944

$564K Total Retail Price of All Prescriptions

Rank: 150 out of 944

431 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 431 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 431 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 9,948 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 821 669 1 1
OMEPRAZOLE 568 448 2 4
LISINOPRIL 435 358 3 3
LEVOTHYROXINE SODIUM 424 326 4 2
ATENOLOL 381 308 5 11
METOPROLOL SUCCINATE 376 348 6 14
FUROSEMIDE 361 318 7 6
METOPROLOL TARTRATE 286 247 8 8
WARFARIN SODIUM 277 253 9 7
AMLODIPINE BESYLATE 270 250 10 5
ALLOPURINOL 204 177 11 22
POTASSIUM CHLORIDE 191 165 12 15
HYDROCODONE-ACETAMINOPHEN 176 141 S3 13 10
LOSARTAN POTASSIUM 172 147 14 16
ATORVASTATIN CALCIUM 172 158 14 13
HYDROCHLOROTHIAZIDE 168 136 16 9
METFORMIN HCL 166 97 17 12
TAMSULOSIN HCL 160 159 18 27
TRAMADOL HCL 144 137 19 21
PREDNISONE 138 136 20 32
LANTUS SOLOSTAR 137 106 21 61
TRIAMTERENE-HCTZ 133 102 22 33
ISOSORBIDE MONONITRATE ER 131 108 23 52
FENOFIBRATE 127 106 24 58
PRAVASTATIN SODIUM 125 93 25 17
ZOLPIDEM TARTRATE 111 102 26 25
DIGOXIN 111 96 26 39
SERTRALINE HCL 108 102 28 23
PANTOPRAZOLE SODIUM 106 75 29 34
FLUTICASONE PROPIONATE 104 88 30 40
GABAPENTIN 101 65 31 18
CITALOPRAM HBR 96 94 32 19
CRESTOR 96 73 32 28
TRAZODONE HCL 93 76 34 45
NIASPAN 93 93 34 76
ALENDRONATE SODIUM 91 52 36 20
GLYBURIDE 89 51 R 37 63
CLOPIDOGREL 87 66 38 36
HUMALOG 80 80 39 109
PEN NEEDLE 80 69 39 100
FLUOXETINE HCL 74 49 41 48
PRAMIPEXOLE DIHYDROCHLORIDE 72 48 42 157
LIPITOR 71 67 43 91
PROPRANOLOL HCL 66 58 44 103
KLOR-CON M10 63 58 45 122
TERAZOSIN HCL 61 60 46 99
LOVASTATIN 60 49 47 26
PLAVIX 60 48 47 55
GLIMEPIRIDE 59 41 49 47
FELODIPINE ER 55 55 50 234
NOVOLOG FLEXPEN 54 34 51 169
VYTORIN 52 40 52 182
PAROXETINE HCL 52 23 52 64
ADVAIR DISKUS 51 46 54 31
CARBIDOPA-LEVODOPA 50 50 55 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.